These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

693 related items for PubMed ID: 22514252

  • 1. Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study.
    Friberg L, Rosenqvist M, Lip GY.
    Circulation; 2012 May 15; 125(19):2298-307. PubMed ID: 22514252
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
    Friberg L, Rosenqvist M, Lip GY.
    Eur Heart J; 2012 Jun 15; 33(12):1500-10. PubMed ID: 22246443
    [Abstract] [Full Text] [Related]

  • 3. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.
    Piccini JP, Stevens SR, Chang Y, Singer DE, Lokhnygina Y, Go AS, Patel MR, Mahaffey KW, Halperin JL, Breithardt G, Hankey GJ, Hacke W, Becker RC, Nessel CC, Fox KA, Califf RM, ROCKET AF Steering Committee and Investigators.
    Circulation; 2013 Jan 15; 127(2):224-32. PubMed ID: 23212720
    [Abstract] [Full Text] [Related]

  • 4. Added predictive ability of the CHA2DS2VASc risk score for stroke and death in patients with atrial fibrillation: the prospective Danish Diet, Cancer, and Health cohort study.
    Larsen TB, Lip GY, Skjøth F, Due KM, Overvad K, Hvilsted Rasmussen L.
    Circ Cardiovasc Qual Outcomes; 2012 May 15; 5(3):335-42. PubMed ID: 22534406
    [Abstract] [Full Text] [Related]

  • 5. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
    Ruiz-Nodar JM, Marín F, Roldán V, Valencia J, Manzano-Fernández S, Caballero L, Hurtado JA, Sogorb F, Valdés M, Lip GY.
    Circ Cardiovasc Interv; 2012 Aug 01; 5(4):459-66. PubMed ID: 22787018
    [Abstract] [Full Text] [Related]

  • 6. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S, Bennett D, Smith DJ.
    Am J Cardiovasc Drugs; 2010 Aug 01; 10(1):37-48. PubMed ID: 20104933
    [Abstract] [Full Text] [Related]

  • 7. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S, Olesen JB, Clémenty N, Lagrenade I, Babuty D, Lip GY, Fauchier L.
    J Cardiovasc Electrophysiol; 2012 Jul 01; 23(7):708-13. PubMed ID: 22268375
    [Abstract] [Full Text] [Related]

  • 8. Risk stratification schemes, anticoagulation use and outcomes: the risk--treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation.
    Sandhu RK, Bakal JA, Ezekowitz JA, McAlister FA.
    Heart; 2011 Dec 01; 97(24):2046-50. PubMed ID: 22076011
    [Abstract] [Full Text] [Related]

  • 9. Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment.
    Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D.
    Thromb Haemost; 2009 May 01; 101(5):938-42. PubMed ID: 19404548
    [Abstract] [Full Text] [Related]

  • 10. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
    Bonde AN, Lip GY, Kamper AL, Hansen PR, Lamberts M, Hommel K, Hansen ML, Gislason GH, Torp-Pedersen C, Olesen JB.
    J Am Coll Cardiol; 2014 Dec 16; 64(23):2471-82. PubMed ID: 25500231
    [Abstract] [Full Text] [Related]

  • 11. Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.
    Jover E, Roldán V, Gallego P, Hernández-Romero D, Valdés M, Vicente V, Lip GY, Marín F.
    Rev Esp Cardiol (Engl Ed); 2012 Jul 16; 65(7):627-33. PubMed ID: 22609214
    [Abstract] [Full Text] [Related]

  • 12. Net clinical benefit of warfarin therapy in elderly Chinese patients with atrial fibrillation.
    Siu CW, Tse HF.
    Circ Arrhythm Electrophysiol; 2014 Apr 16; 7(2):300-6. PubMed ID: 24610776
    [Abstract] [Full Text] [Related]

  • 13. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP, Flaker G, Waldo AL, Corley SD, Greene HL, Safford RE, Rosenfeld LE, Mitrani G, Nemeth M, AFFIRM Investigators.
    Am Heart J; 2005 Apr 16; 149(4):650-6. PubMed ID: 15990748
    [Abstract] [Full Text] [Related]

  • 14. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study.
    Apostolakis S, Lane DA, Guo Y, Buller H, Lip GY.
    J Am Coll Cardiol; 2012 Aug 28; 60(9):861-7. PubMed ID: 22858389
    [Abstract] [Full Text] [Related]

  • 15. Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.
    Potpara TS, Polovina MM, Licina MM, Marinkovic JM, Prostran MS, Lip GY.
    Circ Arrhythm Electrophysiol; 2012 Apr 28; 5(2):319-26. PubMed ID: 22319004
    [Abstract] [Full Text] [Related]

  • 16. Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES study.
    Lip GY, Connolly S, Yusuf S, Shestakovska O, Flaker G, Hart R, Lanas F, Xavier D, Eikelboom J, ERROES Investigators.
    Circ Arrhythm Electrophysiol; 2013 Feb 28; 6(1):31-8. PubMed ID: 23390125
    [Abstract] [Full Text] [Related]

  • 17. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.
    Am J Geriatr Pharmacother; 2009 Jun 28; 7(3):159-66. PubMed ID: 19616184
    [Abstract] [Full Text] [Related]

  • 18. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE.
    N Engl J Med; 2003 Sep 11; 349(11):1019-26. PubMed ID: 12968085
    [Abstract] [Full Text] [Related]

  • 19. The CHADS score role in managing anticoagulation after surgical ablation for atrial fibrillation.
    Ad N, Henry L, Schlauch K, Holmes SD, Hunt S.
    Ann Thorac Surg; 2010 Oct 11; 90(4):1257-62. PubMed ID: 20868824
    [Abstract] [Full Text] [Related]

  • 20. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study.
    Pérez-Gómez F, Alegría E, Berjón J, Iriarte JA, Zumalde J, Salvador A, Mataix L, NASPEAF Investigators.
    J Am Coll Cardiol; 2004 Oct 19; 44(8):1557-66. PubMed ID: 15489085
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.